Consent to the Distribution of New Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Cyproterone acetate 2 mg, ethinylestradiol 0.035 mg Tablet GEHE Medica Produktion GmbH & Co KG., Weimar, Germany Cyprodol Adapalene 0.1% w/w Gel, topical Galderma Laboratories, Alby Sur Cheran, France Differin Letrozole 2.5 mg Tablet, film coated Novartis Pharma Stein AG/SA Inc., Stein, Switzerland Femara Tacrolimus 1 mg, 5 mg Capsules Fujisawa Ireland Limited, Killorglin, County Kerry, Ireland Prograf Tacrolimus 5 mg/mL in 1 mL Infusion, solution Fujisawa Ireland Limited, Killorglin, County Kerry, Ireland Prograf Coal tar solution 4% w/w in 150 mL Shampoo Stiefel Laboratories (Ireland) Limited, Sligo, Ireland and Stiefel Laboratories PTE Limited, Jurong, Singapore Tarmed Polyethylene glycol 400 1% w/v, tetrahydrozoline hydrochloride 0.05% w/v in 15 mL Drops, eye Pfizer Canada Inc., Arnprior, Ontario, Canada Visine Revive Olanzapine 2.5 mg, 5 mg, 7.5 mg, 10 mg Tablets, film coated Lilly del Caribe Inc., Carolina, Puerto Rico and Eli Lilly & Company Limited, Basingstoke, Hants, England Zyprexa Dated this 24th day of June 1997. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.